ESSENTIAL MEDICINES AT PHC -2005 M.PRABHU
CRITERIA BEHIND *Should satisfy health care needs of population *Should be available at all times *In adequate dosage forms *AFFORDABLE
WHO *Proposed this concept *In 1977(by WHA) *Prepared a model list of essential medicines (WHO MODEL LIST OF ESS.MED)
WHO MODEL LIST * NATIONAL HEALTH NEEDS *Efficacy,safety,established quality *Reasonable costs *Revised &updated every 2 yrs
COST EFFECTIVE??? *NOT the UNIT COST *COST OF TOTAL TREATMENT
ESSENTIAL DRUG LIST BASED ON
*Disease prevalence *Treatment facilities *Easy local availability *Financial resources
• CORE MEDICINE
• COMPLEMENTARY MEDICINES
• Basic medicines • safe and cost effective • available at all times
• • • •
Reserve drugs Ineffective basic drugs Rare disorders In italics
COMPLEMENTARY MEDICINES COST EFFECTIVE BUT NOT AFFORDABLE PRIMARY CRITERIA
: REQUIRES MONITORING& DIAGNOSTIC FACILITIES
SECONDARY CRITERIA: HIGHER COST Examples: Aminophylline,amphotericin B,Methotrexate
IN TAMIL NADU PAST 9 YRS UNDER TNMSC CONTINOUS DRUG SUPPLY – 24 DRUG WARE HOUSES LIST OF 271 DRUGS &SUTURE/SURGICAL MATERIALS
AT PHC LEVEL ANNUAL BUDGET ALLOCATION *PLACE INDENT &PASSBOOK FOR DRUG WITHDRAWL *REGULAR STOCK ASSESSMENT ….Eg: PHC ARISIPALAYAM -1,69,000 ANNUALLY 2.15 Rs /Patient
12 th MODEL LIST 2 SEPARATE LIST FOR CORE &COMPLEMENTARY 27 THERAPEUTIC CATEGORIES SQUARE BOX SYMBOL ADDITIONS & CHANGES
13 th MODEL LIST SAME LIST FOR CORE AND COMPLEMENTE\ARY 27 THERAPEUTIC CATEGORIES SQUARE BOX SYMBOL ADDITIONS & CHANGES PRIORITIES FOR FUTURE
DRUG INFORMATION SHEET • • • • • • • •
Name of the drug Mechanism of action Indications for use Dosage regimen Duration of treatment Contraindication Adverse drug reactions Warning (preg,lact)
TYPES BASED ON *THERAPEUTIC CLASSIFICATION *THE ANATOMICAL THERAPEUTIC CHEMICAL CLASSIFICATION SYSTEM (ATC code) *ALPHABETICAL CLASSIFICATION (ATC code)
DRUG LIST INCLUDES . DRUG NAME . USE . ROUTE OF ADMINISTRATION . DOSAGE FORMS . COMPLEMENTARY MEDICINE
REFERENCES • www.WHO.int • www.tnmsc.tn.nic.in.com • THE USE OF ESSENTIAL DRUGS (9 th report) • SELECTION AND USE OF ESSENTIAL MEDICINES 2003